featured
Dual HER2 Blockade in the First-Line Treatment of Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dual HER2 Blockade in the First-Line Treatment of Metastatic Breast Cancer - A Retrospective Population-Based Observational Study in Danish Patients
Breast 2020 Mar 13;[EPub Ahead of Print], T Christensen, T Berg, LB Nielsen, M Andersson, MB Jensen, A KnoopFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.